Catamaran (NASDAQ: CTRX) is one of 13 public companies in the “Managed Health Care” industry, but how does it compare to its rivals? We will compare Catamaran to similar businesses based on the strength of its earnings, dividends, analyst recommendations, institutional ownership, profitability, valuation and risk.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Catamaran and its rivals, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Catamaran 0 0 0 0 N/A
Catamaran Competitors 81 943 1499 27 2.58

As a group, “Managed Health Care” companies have a potential downside of 2.21%. Given Catamaran’s rivals higher probable upside, analysts clearly believe Catamaran has less favorable growth aspects than its rivals.

Institutional and Insider Ownership

90.6% of shares of all “Managed Health Care” companies are held by institutional investors. 2.6% of shares of all “Managed Health Care” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares Catamaran and its rivals revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Catamaran N/A N/A 37.48
Catamaran Competitors $50.73 billion $1.52 billion 9.98

Catamaran’s rivals have higher revenue and earnings than Catamaran. Catamaran is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Risk & Volatility

Catamaran has a beta of -0.18, suggesting that its stock price is 118% less volatile than the S&P 500. Comparatively, Catamaran’s rivals have a beta of 0.70, suggesting that their average stock price is 31% less volatile than the S&P 500.

Profitability

This table compares Catamaran and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Catamaran 1.66% 6.54% 4.25%
Catamaran Competitors 1.83% 11.42% 3.50%

Summary

Catamaran rivals beat Catamaran on 7 of the 9 factors compared.

About Catamaran

Catamaran Corporation (Catamaran) is a provider of pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefit management industry. The Company operates in two segments: PBM and HCIT. The Company offers PBM services, which are marketed under the Catamaran PBM brand, and is engaged in owning and operating a network of mail and specialty pharmacies. In addition, the Company is a national provider of drug benefits to its customers under the federal government’s Medicare Part D program. The Company’s HCIT product offerings include a range of software products for managing prescription drug programs and for drug prescribing and dispensing. The Company’s customers include organizations in the pharmaceutical supply chain, such as pharmacy benefit managers, managed care organizations, self-insured employer groups, unions, third-party healthcare plan administrators, and state and federal government entities.

Receive News & Ratings for Catamaran Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catamaran and related companies with MarketBeat.com's FREE daily email newsletter.